文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

用于 MRI 造影剂的尺寸和 PEG 长度控制的 PEG 化单晶超顺磁性氧化铁纳米复合材料。

Size and PEG Length-Controlled PEGylated Monocrystalline Superparamagnetic Iron Oxide Nanocomposite for MRI Contrast Agent.

机构信息

Medical Imaging Key Laboratory of Sichuan Province and School of Medical Imaging, Affiliated Hospital of North Sichuan Medical College, Nanchong, 637000, People's Republic of China.

Department of Radiology, First People's Hospital of Neijiang, Neijiang 641000, People's Republic of China.

出版信息

Int J Nanomedicine. 2021 Jan 8;16:201-211. doi: 10.2147/IJN.S271461. eCollection 2021.


DOI:10.2147/IJN.S271461
PMID:33447035
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7802780/
Abstract

OBJECTIVE: PEGylated superparamagnetic iron oxide (SPIO) is the most promising alternatives to gadolinium-based contrast agents (GBCAs) in MRI. This paper is to explore the imaging effects of PEGylated SPIO, which is influenced by particle sizes and surface polyethylene glycol (PEG) coating, using as MRI contrast agents at different magnetic field intensities. METHODS: Firstly, nine PEGylated monocrystalline SPIO nanoparticles with different nanocrystal sizes and different molecular weights PEG coating were prepared, and then physical and biological properties were analyzed. Finally, MRI imaging in vivo was performed to observe the imaging performance. RESULTS: Nine PEGylated monocrystalline SPIO nanoparticles have good relaxivities, serum stability, and biosecurity. At the same time, they show different imaging characteristics at different magnetic field intensities. Eight-nanometer SPIO@PEG5k is an effective contrast agent at 3.0 T ( / = 14.0), is an ideal - dual-mode contrast agent at 1.5 T ( / = 6.52), and is also an effective contrast agent at 0.5 T ( / = 2.49), while 4-nm SPIO@PEG5k is a - dual-mode contrast agent at 3.0 T ( / = 5.24), and is a useful contrast agent at 0.5 T ( / = 1.74) and 1.5 T ( / = 2.85). MRI studies in vivo at 3.0 T further confirm that 4-nm SPIO@PEG5k displays excellent - dual-mode contrast enhancement, whereas 8-nm SPIO@PEG5k only displays contrast enhancement. CONCLUSION: PEGylated SPIOs with different nanocrystal sizes and PEG coating can be used as , , or - dual-mode contrast agents to meet the clinical demands of MRI at specific magnetic fields.

摘要

目的:聚乙二醇(PEG)修饰的超顺磁性氧化铁(SPIO)是目前最有希望替代磁共振成像(MRI)中钆基对比剂(GBCA)的材料。本研究旨在探讨不同粒径和表面聚乙二醇(PEG)修饰的 PEG 修饰 SPIO 作为 MRI 对比剂在不同磁场强度下的成像效果。

方法:首先,制备了 9 种具有不同纳米晶体尺寸和不同分子量 PEG 修饰的 PEG 修饰单晶 SPIO 纳米颗粒,并对其理化性质进行了分析。最后,进行了体内 MRI 成像观察其成像性能。

结果:9 种 PEG 修饰单晶 SPIO 纳米颗粒具有良好的弛豫率、血清稳定性和生物安全性。同时,它们在不同磁场强度下表现出不同的成像特征。8nm SPIO@PEG5k 在 3.0T( / = 14.0)下是一种有效的 T1 加权对比剂,在 1.5T( / = 6.52)下是一种理想的 T1/T2 双模式对比剂,在 0.5T( / = 2.49)下也是一种有效的 T2 加权对比剂,而 4nm SPIO@PEG5k 在 3.0T( / = 5.24)下是一种 T1/T2 双模式对比剂,在 0.5T( / = 1.74)和 1.5T( / = 2.85)下是一种有用的 T2 加权对比剂。3.0T 体内 MRI 研究进一步证实,4nm SPIO@PEG5k 显示出优异的 T1/T2 双模式对比增强,而 8nm SPIO@PEG5k 仅显示 T1 加权对比增强。

结论:不同纳米晶体尺寸和 PEG 修饰的 PEG 修饰 SPIO 可作为 T1、T2 或 T1/T2 双模式对比剂,以满足特定磁场下 MRI 的临床需求。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d00/7802780/b2ee4d46941f/IJN-16-201-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d00/7802780/052797d39f7c/IJN-16-201-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d00/7802780/ab867262348c/IJN-16-201-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d00/7802780/5e5e51890ba9/IJN-16-201-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d00/7802780/3959bbfde493/IJN-16-201-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d00/7802780/b2ee4d46941f/IJN-16-201-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d00/7802780/052797d39f7c/IJN-16-201-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d00/7802780/ab867262348c/IJN-16-201-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d00/7802780/5e5e51890ba9/IJN-16-201-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d00/7802780/3959bbfde493/IJN-16-201-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d00/7802780/b2ee4d46941f/IJN-16-201-g0005.jpg

相似文献

[1]
Size and PEG Length-Controlled PEGylated Monocrystalline Superparamagnetic Iron Oxide Nanocomposite for MRI Contrast Agent.

Int J Nanomedicine. 2021

[2]
Studying the effect of particle size and coating type on the blood kinetics of superparamagnetic iron oxide nanoparticles.

Int J Nanomedicine. 2012-8-10

[3]
Polyethylene glycol–coated and folic acid–conjugated superparamagnetic iron oxide nanoparticles

2004

[4]
Sialy Lewis mimetic conjugated to pegylated ultrasmall superparamagnetic iron oxide nanoparticles

2004

[5]
Integration of PEG-conjugated gadolinium complex and superparamagnetic iron oxide nanoparticles as - dual-mode magnetic resonance imaging probes.

Regen Biomater. 2021-11-12

[6]
Synthesis Of PEG-Coated, Ultrasmall, Manganese-Doped Iron Oxide Nanoparticles With High Relaxivity For T/T Dual-Contrast Magnetic Resonance Imaging.

Int J Nanomedicine. 2019-10-24

[7]
Octreotide conjugated to pegylated ultrasmall superparamagnetic iron oxide nanoparticle

2004

[8]
Folate-polyethylene glycol-ultrasmall superparamagnetic iron oxide nanoparticles

2004

[9]
Doxorubicin-modified magnetic nanoparticles as a drug delivery system for magnetic resonance imaging-monitoring magnet-enhancing tumor chemotherapy.

Int J Nanomedicine. 2016-5-12

[10]
Rapid synthesis of PEGylated ultrasmall gadolinium oxide nanoparticles for cell labeling and tracking with MRI.

ACS Appl Mater Interfaces. 2012-8-17

引用本文的文献

[1]
Role of Nanotechnology in Ischemic Stroke: Advancements in Targeted Therapies and Diagnostics for Enhanced Clinical Outcomes.

J Funct Biomater. 2025-1-1

[2]
The role of nanomaterials in revolutionizing ischemic stroke treatment: Current trends and future prospects.

iScience. 2024-11-15

[3]
Utilization of nanomaterials in MRI contrast agents and their role in therapy guided by imaging.

Front Bioeng Biotechnol. 2024-11-19

[4]
MRI-guided photothermal/photodynamic immune activation combined with PD-1 inhibitor for the multimodal combination therapy of melanoma and metastases.

Regen Biomater. 2024-3-14

[5]
Albumin-based nanosystem for dual-modality imaging-guided chem-phototherapy against immune-cold triple-negative breast cancer.

Regen Biomater. 2023-8-31

[6]
Superparamagnetic Nanocrystals Clustered Using Poly(ethylene glycol)-Crosslinked Amphiphilic Copolymers for the Diagnosis of Liver Cancer.

Pharmaceutics. 2023-8-25

[7]
Designing Smart Iron Oxide Nanoparticles for MR Imaging of Tumors.

Chem Biomed Imaging. 2023-5-4

[8]
Ultra-small superparamagnetic iron oxide nanoparticles for intra-articular targeting of cartilage in early osteoarthritis.

Regen Biomater. 2023-5-11

[9]
Dopamine multivalent-modified polyaspartic acid for MRI-guided near-infrared photothermal therapy.

Regen Biomater. 2023-3-14

[10]
Recent Advances in Imaging Agents Anchored with pH (Low) Insertion Peptides for Cancer Theranostics.

Molecules. 2023-2-26

本文引用的文献

[1]
Assembly-Controlled Magnetic Nanoparticle Clusters as MRI Contrast Agents.

ACS Biomater Sci Eng. 2020-5-11

[2]
Single-Molecule Mechanics of Catechol-Iron Coordination Bonds.

ACS Biomater Sci Eng. 2017-6-12

[3]
Multivalent manganese complex decorated amphiphilic dextran micelles as sensitive MRI probes.

J Mater Chem B. 2015-2-28

[4]
Bombesin-functionalized superparamagnetic iron oxide nanoparticles for dual-modality MR/NIRFI in mouse models of breast cancer.

Int J Nanomedicine. 2019-8-21

[5]
Gadolinium-based contrast agents induce gadolinium deposits in cerebral vessel walls, while the neuropil is not affected: an autopsy study.

Acta Neuropathol. 2018-5-10

[6]
Advocating the Development of Next-Generation High-Relaxivity Gadolinium Chelates for Clinical Magnetic Resonance.

Invest Radiol. 2018-7

[7]
Relaxivity of Ferumoxytol at 1.5 T and 3.0 T.

Invest Radiol. 2018-5

[8]
T-T Dual-Modal Magnetic Resonance Imaging: From Molecular Basis to Contrast Agents.

ACS Nano. 2017-6-14

[9]
Iron Oxide Based Nanoparticles for Multimodal Imaging and Magnetoresponsive Therapy.

Chem Rev. 2015-10-14

[10]
Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy.

Radiology. 2015-5-5

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索